Honghe Wan
9Patents
4h-index
27Co-inventors
53Inventor score
Filing activity: Aug 8, 2007 → Apr 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9273057B2 | Imidazotriazinecarbonitriles useful as kinase inhibitors | Chemistry; Metallurgy | 26 | Active |
| US8202881B2 | JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | Chemistry; Metallurgy | 10 | Active |
| US7531539B2 | Pyrrolotriazine kinase inhibitors | Human Necessities | 9 | Active |
| US8673933B2 | JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer | Chemistry; Metallurgy | 5 | Active |
| US8940736B2 | Imidazotriazinecarbonitriles useful as kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9556178B2 | Imidazotriazinecarbonitriles useful as kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9593116B2 | Crystalline forms of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide for the treatment of myeloproliferative disorders | Human Necessities | 0 | Active |
| US11485741B2 | Macrocyclic toll-like receptor 7 (TLR7) agonists | Human Necessities | 0 | Active |
| US10550125B2 | Prodrugs of imidazotriazine compounds as CK2 inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.